SiBionics showcases automated insulin delivery technologies at EASD 2026
Medical technology developer SiBionics presented continuous glucose monitoring systems and automated insulin delivery solutions at the European Association for the Study of Diabetes 2026 conference
MILAN, Oct. 4, 2026 - At the European Association for the Study of Diabetes (EASD) 2026, SiBionics showcased its automated insulin delivery technologies, presenting three exhibition chapters. The first, "Beyond Glucose," explored glucose, ketone, and combined monitoring. The second, "Act Earlier," delved into multimodal sensing and insulin delivery.
The third, "Go Further," looked toward broader biosensing applications. A symposium followed, chaired by Prof. Mark Evans and Dr. Guido Freckmann, where various experts presented on CGM, ketone monitoring, and integrated care in type 3c diabetes. One standout development was the niia signature investigational device, a wearable patch combining CGM, insulin delivery, and an automated glucose control algorithm.
This device aims to simplify automated insulin delivery by integrating multiple functions into one unit. Through these advancements, PharmaSens and SiBionics aim to make future automated insulin delivery more user-friendly and integrated.
Written by urgent.news from Vietnam Investment Review's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
